Clinical Trial Update: Botulinum Toxin in Peripheral Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating botulinum toxin for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Postherpetic Neuralgia

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Hospital Ambroise Paré Paris | Conditions: Postherpetic Neuralgia, Diabetic Polyneuropathies | Phase 4 | Status: COMPLETED